Nucleoside transporters are critical to the uptake and antioxidant activity of 7,8-dihydroneopterin in monocytic cells

References

• Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007;45(2):27–37.
   PubMedGoogle Scholar
• Wahl SM, Wong H, McCartney‐Francis N. Role of growth factors in inflammation and repair. J Cell Biochem. 1989;40(2):193–199.
   PubMed Web of Science ®Google Scholar
• Mittal M, Siddiqui MR, Tran K, et al. Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal. 2014;20(7):1126–1167.
   PubMed Web of Science ®Google Scholar
• Slauch JM. How does the oxidative burst of macrophages kill bacteria? Still an open question. Mol Microbiol. 2011;80(3):580–583.
   PubMed Web of Science ®Google Scholar
• Forman HJ, Torres M. Signaling by the respiratory burst in macrophages. IUBMB Life. 2001;51(6):365–371.
   PubMed Web of Science ®Google Scholar
• Lo H-M, Chen C-L, Yang C-M, et al. The carotenoid lutein enhances matrix metalloproteinase-9 production and phagocytosis through intracellular ROS generation and ERK1/2, p38 MAPK, and RARβ activation in murine macrophages. J Leukoc Biol. 2013;93(5):723–735.
   PubMed Web of Science ®Google Scholar
• Vida C, de Toda IM, Cruces J, et al. Role of macrophages in age-related oxidative stress and lipofuscin accumulation in mice. Redox Biol. 2017;12:423–437.
   PubMed Web of Science ®Google Scholar
• Pietarinen P, Raivio K, Devlin RB, et al. Catalase and glutathione reductase protection of human alveolar macrophages during oxidant exposure in vitro. Am J Respir Cell Mol Biol. 1995;13(4):434–441.
   PubMed Web of Science ®Google Scholar
• Gieseg SP, Crone EM, Flavall EA, et al. Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis. Br J Pharmacol. 2008;153(4):627–635.
   PubMed Web of Science ®Google Scholar
• Schoedon G, Troppmair J, Fontana A, et al. Biosynthesis and metabolism of pterins in peripheral blood mononuclear cells and leukemia lines of man and mouse. Eur J Biochem. 1987;166(2):303–310.
   PubMedGoogle Scholar
• Troppmair J, Nachbaur K, Herold M, et al. In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS). Clin Exp Immunol. 1988;74(3):392–397.
   PubMed Web of Science ®Google Scholar
• Duggan S, Rait C, Gebicki JM, et al. Inhibition of protein oxidation by the macrophage-synthesised antioxidant 7,8-dihydroneopterin. Redox Rep. 2001;6(3):188–190.
   PubMed Web of Science ®Google Scholar
• Gieseg SP, Maghzal G, Glubb D. Inhibition of haemolysis by the macrophage synthesized antioxidant, 7, 8-dihydroneopterin. Redox Rep. 2000;5:2–3.
   Web of Science ®Google Scholar
• Widner B, Mayr C, Wirleitner B, et al. Oxidation of 7,8-dihydroneopterin by hypochlorous acid yields neopterin . Biochem Biophys Res Commun. 2000;275(2):307–311.
   PubMed Web of Science ®Google Scholar
• Gieseg SP, Whybrow J, Glubb D, et al. Protection of U937 cells from free radical damage by the macrophage synthesized antioxidant 7,8-dihydroneopterin. Free Radic Res. 2001;35(3):311–318.
   PubMed Web of Science ®Google Scholar
• Gieseg SP, Cato S. Inhibition of THP-1 cell-mediated low-density lipoprotein oxidation by the macrophage-synthesised pterin, 7,8-dihydroneopterin. Redox Rep. 2003;8(2):113–115.
   PubMed Web of Science ®Google Scholar
• Shchepetkina AA, Hock BD, Miller A, et al. Effect of 7,8-dihydroneopterin mediated CD36 down regulation and oxidant scavenging on oxidised low-density lipoprotein induced cell death in human macrophages. Int J Biochem Cell Biol. 2017;87:27–33.
   PubMed Web of Science ®Google Scholar
• Baird SK, Reid L, Hampton MB, et al. OxLDL induced cell death is inhibited by the macrophage synthesised pterin, 7,8-dihydroneopterin, in U937 cells but not THP-1 cells. Biochim Biophys Acta. 2005;1745(3):361–369.
   PubMed Web of Science ®Google Scholar
• Baldwin SA, Beal PR, Yao SYM, et al. The equilibrative nucleoside transporter family, SLC29. Pflugers Arch. 2004;447(5):735–743.
   PubMed Web of Science ®Google Scholar
• Cass CE, Young JD, Baldwin SA, et al. Nucleoside transporters of mammalian cells. Pharm Biotechnol. 1999;12:313–352.
   PubMedGoogle Scholar
• Harding CO, Neff M, Wild K, et al. The fate of intravenously administered tetrahydrobiopterin and its implications for heterologous gene therapy of phenylketonuria. Mol Genet Metab. 2004;81(1):52–57.
   PubMed Web of Science ®Google Scholar
• Sawabe K, Yamamoto K, Harada Y, et al. Cellular uptake of sepiapterin and push-pull accumulation of tetrahydrobiopterin. Mol Genet Metab. 2008;94(4):410–416.
   PubMed Web of Science ®Google Scholar
• Sugiyama T, Levy BD, Michel T. Tetrahydrobiopterin recycling, a key determinant of endothelial nitric-oxide synthase-dependent signaling pathways in cultured vascular endothelial cells. J Biol Chem. 2009;284(19):12691–12700.
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55–63.
   PubMed Web of Science ®Google Scholar
• Lindsay A, Janmale T, Draper N, et al. Measurement of changes in urinary neopterin and total neopterin in body builders using SCX HPLC. Pteridines. 2014;25(2):53–63.
   Web of Science ®Google Scholar
• Young JD, Yao SYM, Sun L, et al. Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins. Xenobiotica. 2008;38(7-8):995–1021.
   PubMed Web of Science ®Google Scholar
• Nivillac NMI, Bacani J, Coe IR. The life cycle of human equilibrative nucleoside transporter 1: from ER export to degradation. Exp Cell Res. 2011;317(11):1567–1579.
   PubMed Web of Science ®Google Scholar
• Belt JA, Marina NM, Phelps DA, et al. Nucleoside transport in normal and neoplastic cells. Adv Enzyme Regul. 1993;33:235–252.
   PubMedGoogle Scholar
• Pastor-Anglada M, Cano-Soldado P, Errasti-Murugarren E, et al. SLC28 genes and concentrative nucleoside transporter (CNT) proteins. Xenobiotica. 2008;38(7-8):972–994.
   PubMed Web of Science ®Google Scholar
• Gieseg SP, Maghzal G, Glubb D. Protection of erythrocytes by the macrophage synthesized antioxidant 7,8 dihydroneopterin. Free Radic Res. 2001;34(2):123–136.
   PubMed Web of Science ®Google Scholar
• Kappler M, Gerry AB, Brown E, et al. Aqueous peroxyl radical exposure to THP-1 cells causes glutathione loss followed by protein oxidation and cell death without increased caspase-3 activity. Biochim Biophys Acta. 2007;1773(6):945–953.
   PubMed Web of Science ®Google Scholar
• Katouah H, Chen A, Othman I, et al. Oxidised low density lipoprotein causes human macrophage cell death through oxidant generation and inhibition of key catabolic enzymes. Int J Biochem Cell Biol. 2015;67:34–42.
   PubMed Web of Science ®Google Scholar
• Gieseg SP, Leake DS, Flavall EM, et al. Macrophage antioxidant protection within atherosclerotic plaques. Front Biosci (Landmark Ed)). 2009;14:1230–1246.
   PubMed Web of Science ®Google Scholar
• Strauss PR. Effects of serum on membrane transport. II. Serum and the stimulation of adenosine transport, a possible mechanism. J Cell Biol. 1974;60(3):571–585.
   PubMed Web of Science ®Google Scholar
• Plagemenn PG, Richey DP, Zylka JM, et al. Cell cycle and growth stage-dependent changes in the transport of nucleosides, hypoxanthine, choline, and deoxyglucose in cultured Novikoff rat hepatoma cells. J Cell Biol. 1975;64(1):29–41.
   PubMed Web of Science ®Google Scholar
• Valdés R, Casado FJ, Pastor-Anglada M. Cell-cycle-dependent regulation of CNT1, a concentrative nucleoside transporter involved in the uptake of cell-cycle-dependent nucleoside-derived anticancer drugs. Biochem Biophys Res Commun. 2002;296(3):575–579.
   PubMed Web of Science ®Google Scholar